OR WAIT null SECS
Rita Peters is editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.
By adapting techniques from other sciences-and exploring better tools for biologics drug development-researchers are addressing challenges of protein characterization.
Proteins must be characterized at many phases of biopharmaceutical research, development, and manufacturing, each with differing demands and requirements. Instrument capabilities-and limitations-influence the speed and success of development efforts. Researchers from biopharma, contract service organizations, and academia face challenges of selecting and optimizing appropriate techniques for protein characterization needs.
Experts interviewed by Pharmaceutical Technology shared similar concerns about the need to conduct complex protein characterization studies under the pressures of tight timelines and urgency to get new drug products to clinic and approval.
eBook: Bio/Pharma Laboratory Best Practices 2018
When referring to this article, please cite it as R. Peters, "Complex Protein Studies Demand Dynamic Techniques," Pharmaceutical Technology Bio/Pharma Laboratory Best Practices eBook (November 2018).